Improving Proteostasis of Trafficking-Deficient GABA A Receptor Variants by Activating IRE1
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00227 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Xu Fu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, 10900 Euclid Ave, Cleveland, Ohio 44106, United States. Hauptthemen laut MEDLINE: Receptors, GABA-A, Protein Serine-Threonine Kinases, Proteostasis, Endoribonucleases. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Gamma-aminobutyric acid type A receptors (GABAARs) are essential for maintaining the excitation-inhibition balance in the central nervous system. Genetic variations of GABAARs result in a variety of neurological disorders, such as epilepsy. A key pathogenic mechanism involves protein misfolding and defective assembly of GABAARs in the endoplasmic reticulum (ER), resulting in impaired surface expression and loss of function. Here, we investigated three trafficking-deficient variants of the GABAAR α1 subunit (GABRA1), including D219N (ClinVar Variation ID: 127232), G251D (Variation ID: 419523), and P260L. We demonstrated that selective pharmacological activation of the IRE1/XBP1s signaling arm of the unfolded protein response using IXA62, IXA554, and IXA105 increases total and surface protein levels of all three α1 variants without affecting wild-type receptor protein levels in HEK293T cells. Patch-clamping recordings further showed that treatment with IXA62, IXA554, and IXA105 increases the peak GABA-evoked current amplitudes in HEK293T cells expressing α1(D219N) and α1(G251D). Mechanistic analyses revealed that IXA62 and IXA554 remodel the GABAAR-associated proteostasis network by promoting folding and anterograde trafficking while inhibiting degradation in HEK293T cells expressing α1(D219N) variant and human iPSC-derived neurons carrying α1(G251D) variant. These results suggest that selective IRE1/XBP1s activation pharmacologically can be further developed to provide a potential therapeutic avenue for genetic epilepsies caused by GABAAR trafficking defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, 10900 Euclid Ave, Cleveland, Ohio 44106, United States.
- Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
- Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States.
- Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506, United States.
- Department of Molecular and Cellular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
ORCID-Profile: Christopher I Richards, R Luke Wiseman, Jeffery W Kelly, Ting-Wei Mu
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- National Institute of Neurological Disorders and Stroke
- American Heart Association
- National Institute on Aging
- National Institute of General Medical Sciences
- Brain Research Foundation
Zitieren
APA
Fu, X., Wang, Y. J., Lee, K., Ahn, L. Y., Chen, X., Harvey, B. T., Wang, M., Seibert, H., Zhang, P. P., Guerrero, A., Schaffer, A. E., Richards, C. I., Wiseman, R. L., Kelly, J. W., & Mu, T. W. (2025). Improving Proteostasis of Trafficking-Deficient GABA A Receptor Variants by Activating IRE1. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00227
Vancouver
Fu X, Wang YJ, Lee K, Ahn LY, Chen X, Harvey BT, et al. Improving Proteostasis of Trafficking-Deficient GABA A Receptor Variants by Activating IRE1. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00227
BibTeX
@article{Fu2025,
author = {Fu, Xu and Wang, Ya-Juan and Lee, KyungA and Ahn, Lucie Y and Chen, Xi and Harvey, Brock T and Wang, Meng and Seibert, Hailey and Zhang, Pei-Pei and Guerrero, Adrian and Schaffer, Ashleigh E and Richards, Christopher I and Wiseman, R Luke and Kelly, Jeffery W and Mu, Ting-Wei},
title = {Improving Proteostasis of Trafficking-Deficient GABA A Receptor Variants by Activating IRE1},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00227}
}
EUVIMED